Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia?
Children with sickle-cell anaemia are predisposed to thrombotic strokes, the aetiology of which is unclear. We propose that erythropoietin, produced in response to chronic anaemia, is responsible for changes in platelet reactivity with a resulting increase in thromboses. This hypothesis is based on reports of enhanced aggregability of erythropoietin-driven platelets and an increased rate of thrombosis in patients receiving large doses of recombinant erythropoietin. Experiments in animals have shown that erythropoietin stimulates synthesis of platelets, that erythropoietin-driven platelets are hyper-reactive compared with age-matched control platelets, and that erythropoietin is pro-thrombotic. These data suggest that erythropoietin-dependent changes in platelet reactivity may potentiate thrombosis in sickle-cell anaemia, particularly in children who, compared with adults, have markedly higher erythropoietin concentrations and incidence of strokes.
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.
G L
GL
Dale
L
L
Alberio
D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D000818:Animals; D016022:Case-Control Studies; D002561:Cerebrovascular Disorders / Q000209:etiology; D002648:Child; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D015539:Platelet Activation / Q000502:physiology; D010974:Platelet Aggregation / Q000502:physiology; D011994:Recombinant Proteins; D013927:Thrombosis / Q000209:etiology*
D011994:Recombinant Proteins; D004921:Erythropoietin